Simpler Grants.gov #RFA-OD-27-005

NIH INCLUDE Project: Phased Innovation Clinical Trials for Down Syndrome Research

The National Institutes of Health (NIH) is seeking applications for the INCLUDE Project, which funds milestone-driven, phased innovation (R61/R33) clinical trials focused on treating critical and co-occurring health conditions in individuals with Down syndrome. - Government Buyer: - National Institutes of Health (NIH) - OEMs and Vendors: - NIH is the only organization mentioned; no commercial OEMs or vendors are specified - Products/Services Requested: - Clinical trial development and support services for Down syndrome research - No specific products, part numbers, or commercial equipment requested - Milestone-driven, exploratory and developmental phased innovation (R61/R33) grant applications - Up to two years for preliminary studies (R61 phase) - Up to three years for clinical trial support (R33 phase) - Unique or Notable Requirements: - Research must be focused on clinical trials for Down syndrome - Projects must be milestone-driven, with clear, measurable objectives for the R61 phase - Broad eligibility: for-profit, nonprofit, government, educational, tribal, and foreign organizations may apply - Estimated total funding available is $3,000,000, with four awards expected

Description

The NIH INCLUDE Project aims to improve health and quality-of-life for individuals with Down syndrome by supporting exploratory and developmental phased innovation grant applications. These grants support the development of clinical trials to treat critical and co-occurring health conditions in individuals with Down syndrome, with milestone-driven research aims. The project period may not exceed five years, with up to two years for preliminary studies (R61 phase) followed by up to three years for clinical trial support (R33 phase). This funding opportunity requires measurable milestones for the R61 phase.

View original listing